Skip to content

Effects of glycopeptide beverage on post-exercise recovery: a randomized controlled trial.

Effects of glycopeptide beverage on post-exercise recovery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000034696
Enrollment
Unknown
Registered
2020-07-15
Start date
2020-07-20
Completion date
Unknown
Last updated
2020-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-exercise recovery

Interventions

1:glycopeptide beverage
2:drinking water

Sponsors

Peking University Third Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: 1. Healthy men aged 18-35 years old; 2. Subjects with exercise habits (i.e. exercise for at least 1 year, 3 times / week, more than 60 minutes each time).

Exclusion criteria

Exclusion criteria: 1. BMI=28kg/m2 2. Smokers; 3. Patients who have participated in or are participating in other clinical trials within three months after taking the study product for the first time; 4. Patients who are about to receive or are receiving medication; 5. Patients with serious organic diseases of heart, liver, kidney and blood system or patients with chronic diseases; 6. Patients who can't perform the physical function test and can't answer the questionnaire questions correctly; 7. Patients who are unable to follow the trial procedure; 8. Patients who are allergic to the ingredients of the test product; 9. Patients who refuse to sign informed consent.

Design outcomes

Primary

MeasureTime frame
hydration related indicators;Fatigue related indicators;

Secondary

MeasureTime frame
Antioxidant indicators;Immune-related indicators; substance and energy metabolism;

Countries

China

Contacts

Public ContactChang Cuiqing

Peking University Third Hospital

13521960678@163.com+86 13521960678

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026